Background Allergy to peanut is one of the leading causes of anaphylactic reactions among
food allergic patients. Immunization against peanut allergy with a safe and protective …

Background Peanut allergy is a severe and increasingly frequent disease with high medical,
psychosocial, and economic burden for affected patients and wider society. A causal, safe …

Background Virus‐like particle (VLP) Peanut is a novel immunotherapeutic vaccine
candidate for the treatment of peanut allergy. The active pharmaceutical ingredient …

Food allergy is a growing health concern worldwide. Current allergen-specific
immunotherapy (AIT) approaches require frequent dosing over extended periods of time and …

Background Peanuts are the most common food to provoke fatal or near-fatal anaphylactic
reactions. Treatment with an anti-hIgE mAb is efficacious but requires frequent parenteral …

Background Treatments to reverse peanut allergy remain elusive. Current clinical
approaches using peanut oral/sublingual immunotherapy are promising, but concerns about …

Background Immunotherapy for peanut allergy may be limited by the risk of adverse
reactions. Objective To investigate the safety and immunologic effects of a vaccine …

Background: Numerous strategies have been proposed for the treatment of peanut allergies,
but despite the steady advancement in our understanding of atopic immune responses and …

Background: Peanut allergy is the most prevalent and dangerous food allergy. Peanuts
consist of a large number of different allergens and peanut-allergic patients are frequently …

Peanut allergy is an IgE-mediated, persisting immune disorder that is of major concern
worldwide. Currently, no routine immunotherapy is available to treat this often severe and …